<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03045536</url>
  </required_header>
  <id_info>
    <org_study_id>148/15</org_study_id>
    <nct_id>NCT03045536</nct_id>
  </id_info>
  <brief_title>Evaluation of Partial and Total Femoral Replacement</brief_title>
  <acronym>EFeRe</acronym>
  <official_title>Evaluation of Partial and Total Femoral Replacement Treated in a Single Orthopedic Centre</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Technische Universität München</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Technische Universität München</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Several surgical options for the reconstruction of massive bone defects have been described
      and include biologic methods with autografts and allografts, and the use of tumor
      endoprostheses (total femoral replacement, TFR). Several types of modular TFR are available,
      but nevertheless unpredictable outcomes and high complication rates have been described from
      most authors. The aim of the present study was to compare complication rates after TFR
      performed with modular total femur prosthesis MML (Fa. ESKA/Orthodynamics) in patients with
      and without malignant disease.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2016</start_date>
  <completion_date type="Anticipated">April 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Survival of device</measure>
    <time_frame>2 years</time_frame>
    <description>Any device-related complications are defined failure</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Survival, Prostheses</condition>
  <arm_group>
    <arm_group_label>Patients with TFR</arm_group_label>
    <description>Patients treated with TFR for oncologic or non-oncologic reason</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MML (Fa. ESKA/Orthodynamics)</intervention_name>
    <description>Classification of complications according to MSTS</description>
    <arm_group_label>Patients with TFR</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The investigators retrospectivel review our institution's database for patients who
        underwent resection of the partial or whole femur due to bone tumors or failed revision
        arthroplasties and reconstruction by TFR from January 1995 to January 2011.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Total or partial femoral replacement

        Exclusion Criteria:

          -  Failure of device
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>norbert harrasser</last_name>
    <role>Principal Investigator</role>
    <affiliation>Klinikum rechts der Isar</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>norbert harrasser</last_name>
    <phone>15232716657</phone>
    <email>norbert.harrasser@gmx.net</email>
  </overall_contact>
  <location>
    <facility>
      <name>Klinikum rechts der Isar</name>
      <address>
        <city>Munich</city>
        <zip>80992</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>norbert harrasser</last_name>
      <phone>15232716657</phone>
      <email>norbert.harrasser@gmx.net</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 4, 2017</study_first_submitted>
  <study_first_submitted_qc>February 6, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 7, 2017</study_first_posted>
  <last_update_submitted>April 24, 2017</last_update_submitted>
  <last_update_submitted_qc>April 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 25, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Technische Universität München</investigator_affiliation>
    <investigator_full_name>Harrasser</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prosthesis Failure</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

